Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Interest & Investment Income (2016 - 2025)

Cytosorbents' Interest & Investment Income history spans 15 years, with the latest figure at -$746000.0 for Q4 2025.

  • Quarterly results put Interest & Investment Income at -$746000.0 for Q4 2025, down 19.55% from a year ago — trailing twelve months through Dec 2025 was -$2.6 million (down 86.76% YoY), and the annual figure for FY2025 was -$2.6 million, down 86.7%.
  • Interest & Investment Income for Q4 2025 was -$746000.0 at Cytosorbents, down from -$645000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $53748.0 in Q4 2022 to a low of -$746000.0 in Q4 2025.
  • The 5-year median for Interest & Investment Income is -$21897.0 (2021), against an average of -$200403.8.
  • The sharpest move saw Interest & Investment Income soared 337.19% in 2022, then crashed 8995.66% in 2025.
  • Year by year, Interest & Investment Income stood at $12294.0 in 2021, then soared by 337.19% to $53748.0 in 2022, then plummeted by 197.17% to -$52229.0 in 2023, then plummeted by 1094.74% to -$624000.0 in 2024, then dropped by 19.55% to -$746000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at -$746000.0, -$645000.0, and -$616000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.